Natco Pharma gets FDA approval for Carfilzomib Vials ANDA
Natco Pharma Limited said that its marketing partner – Breckenridge Pharmaceutical Inc. (BPI), has secured approval from the US Food and Drug Administration (FSA) for its abbreviated new drug application (ANDA) for Carfilzomib Vials ANDA (generic for KYPROLIS). Developed by Onyx Pharmaceuticals, KYPROLIS (carfilzomib) is indicated in the US for the treatment of multiple myeloma […]